iiMED Medical Solutions, LLC

iiMED Medical Solutions, LLC, based in Mexico, develops innovative medical device solutions that enhance patient care and safety across healthcare environments. Founded in 2003, iiMED Medical Solutions specializes in medical devices aimed at improving patient outcomes. The company has undergone strategic pivots to adapt to market needs. Headquartered in Mexico, iiMED has completed 7 deals to date.

Its recent funding round, a Buyout, raised USD 127. 500 mn from Centre Partners, marking the total amount raised at USD 127. 500 mn. iiMED Medical Solutions focuses on developing and manufacturing medical device solutions that enhance safety for patients and caregivers.

Its primary offerings include diagnostic in vitro (IVD) tests, wearable patient monitoring sensors, and advanced pharmaceutical delivery devices. These solutions target healthcare challenges such as wound care, infection control, and accurate medication delivery, catering to a diverse clientele that includes healthcare providers and pharmaceutical companies primarily in North America and selected international markets. All products meet stringent regulatory standards, assuring quality for healthcare professionals and patients. iiMED Medical Solutions generates revenue through B2B sales, establishing partnerships with healthcare organizations and distributors.

Their approach includes direct sales agreements, accommodating both bulk and smaller orders. Key products like the UnoDose™ single-use metered dosing applicators are marketed to foster long-term relationships with clients, enhancing repeat business through tailored pricing structures for various client segments. iiMED Medical Solutions plans to launch new products designed to meet evolving healthcare needs, with specific release dates to be determined. The company seeks to expand its market presence into additional regions, focusing on strategic international markets by the end of the upcoming fiscal year.

Recent funding from the Buyout will be utilized to support these expansion initiatives and product development, ensuring that iiMED continues to address critical healthcare challenges effectively.